Review of local injection of anti-TNF for perianal fistulising Crohn’s disease

BACKGROUND: Perianal fistulising Crohn’s disease (PFCD) affects a third of Crohn’s disease patients and represents a disabling phenotype with poor outcome. The anti-tumour necrosis factor alpha (TNF) therapies have been shown to maintain clinical remission in a third of patients after 1 year of trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Adegbola, Samuel O., Sahnan, Kapil, Tozer, Philip J, Phillips, Robin KS, Faiz, Omar D, Warusavitarne, Janindra, Hart, Ailsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635080/
https://www.ncbi.nlm.nih.gov/pubmed/28900730
http://dx.doi.org/10.1007/s00384-017-2899-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635080/
https://www.ncbi.nlm.nih.gov/pubmed/28900730
http://dx.doi.org/10.1007/s00384-017-2899-0

Ejemplares similares